Pilocarpine Hydrochloride Tablet, Film Coated
Product Images NDC 69292-265

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Pilocarpine Hydrochloride (NDC 69292-265). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amici Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pilocarpine-5mg-100ct (Pilocarpine 5mg [email protected])

Label for Pilocarpine Hydrochloride Tablets, USP 5 mg, film-coated, oral. The label indicates 100 tablets per bottle. It is a prescription drug labeled by Amici Pharmaceuticals LLC. The NDC code is 69292-265-01. The label includes dosage instructions, storage conditions, and manufacturing details from Immegenix LLC.*

FDA Label Image

Child-pugh-scoring-table-1 (Child Pugh Scoring Table 1)

A data table titled Clinical and Biochemical Measurements that lists measurement parameters such as Encephalopathy (grade), Ascites, Bilirubin, Albumin, Prothrombin Time, and Bilirubin for Primary Biliary Cirrhosis. The table includes points scored for increasing abnormality with values categorized under columns 1, 2, and 3 indicating severity and corresponding measurement ranges or conditions.*

FDA Label Image

Head-neck-table-1 (Head Neck Table 1)

A data table presenting adverse event frequencies comparing Pilocarpine HCl at 10 mg three times daily, Pilocarpine HCl at 5 mg three times daily, and placebo. Events include sweating, nausea, rhinitis, diarrhea, chills, flushing, urinary frequency, dizziness, and asthenia, with corresponding incidence percentages or counts.*

FDA Label Image

Head-neck-table-2 (Head Neck Table 2)

A data table comparing adverse events between Pilocarpine Hydrochloride (5-10 mg t.i.d., 15-30 mg/day) and placebo groups. The table lists event types such as headache, dyspepsia, lacrimation, edema, abdominal pain, amblyopia, vomiting, pharyngitis, and hypertension, with corresponding counts and percentages for each group.*

FDA Label Image

Pilocarpine-hcl (Pilocarpine HCl)

Chemical structure of Pilocarpine Hydrochloride. The diagram shows the molecular arrangement including a methylated imidazole ring, a five-membered lactone ring, and the chloride ion associated as the salt form.*

FDA Label Image

Sjogren-syndrome-table-1 (Sjogren Syndrom Table 1)

A data table comparing incidence of adverse events between Pilocarpine Hydrochloride 5 mg taken four times daily (20 mg/day) and placebo. Events include sweating, urinary frequency, nausea, flushing, rhinitis, diarrhea, chills, increased salivation, and asthenia with corresponding occurrence counts and percentages in each group.*

FDA Label Image

Sjrogren-syndrome-table-2 (Sjogren Syndrome Table 2)

A data table comparing the incidence of adverse events between Pilocarpine Hydrochloride 5 mg (20 mg/day) and placebo. It lists various adverse events such as headache, flu syndrome, dyspepsia, dizziness, and others, showing the number and percentage of subjects affected in each treatment group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.